Entrada Therapeutics, Inc.

Nasdaq:TRDA

Pharmaceutical Preparations·BOSTON, MA

CEO

Doshi Dipal

CFO

Wentworth Kory James

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/26/26	→
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/6/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	2/27/25	→
10-Q	Q3 2024	9/30/24	11/5/24	→
↓

Earnings Releases (8-K)

19 shown

Filed	Period
2/26/26	Q1 FY2026	→
1/8/26	Q4 FY2026	→
11/6/25	Q4 FY2025	→
8/6/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
2/27/25	Q1 FY2025	→
↓

News (8-K)

27 shown

Filed	Type	Description
6/11/25	Vote	Submission of Matters to a Vote of Security Holders	→
6/3/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
4/29/25	Other	Costs Associated with Exit or Disposal Activities	→
3/24/25	Reg FD	Regulation FD Disclosure	→
2/24/25	Reg FD	Regulation FD Disclosure	→
2/3/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

18 shown

Filed	Form	Description
2/26/26	S-8	S-8	→
11/6/25	S-3	S-3	→
4/25/25	ARS	ARS	→
3/25/25	S-8	S-8	→
2/27/25	S-8	S-8	→
6/24/24	424B5	424B5	→
↓

Filing History(425 filings)

TypeDateAccessionPeriodSize

144

Mar 9, 2026

0001950047-26-002377

—

7.8 KB

144

Mar 9, 2026

0001950047-26-002366

—

6.3 KB

Mar 6, 2026

0001725663-26-000002FORM 4

Mar 4, 2026

5.3 KB

144

Mar 4, 2026

0001950047-26-002210

—

6.1 KB

Mar 3, 2026

0001613084-26-000001FORM 4

Mar 1, 2026

11.4 KB

Mar 3, 2026

0001725663-26-000001FORM 4

Mar 1, 2026

11.5 KB

Mar 3, 2026

0001873392-26-000001FORM 4

Mar 1, 2026

11.4 KB

Mar 3, 2026

0001873394-26-000001FORM 4

Mar 1, 2026

11.4 KB

S-8

Feb 26, 2026

0001104659-26-020086FORM S-8

—

238.0 KB

10-K

Feb 26, 2026

0001689375-26-00001110-K

Dec 31, 2025

15.6 MB

8-K

Feb 26, 2026

0001689375-26-0000098-K

Feb 26, 2026

240.7 KB

8-K

Jan 8, 2026

0001689375-26-0000038-K

Jan 8, 2026

207.8 KB

EFFECT

Dec 3, 2025

9999999995-25-003504

—

1.8 KB

SCHEDULE 13G

Nov 25, 2025

0001193125-25-297315

—

126.5 KB

Nov 24, 2025

0001725663-25-000004FORM 4

Nov 21, 2025

5.3 KB

Nov 24, 2025

0001193125-25-2936984

Nov 20, 2025

18.2 KB

144

Nov 21, 2025

0001950047-25-009207

—

5.6 KB

SCHEDULE 13D/A

Nov 18, 2025

0001674324-25-000005

—

15.6 KB

Nov 18, 2025

0001664281-25-000003

Nov 14, 2025

6.9 KB

Nov 18, 2025

0001231919-25-000522

Nov 14, 2025

15.7 KB

144

Nov 14, 2025

0001674324-25-000003

—

4.8 KB

SCHEDULE 13G/A

Nov 14, 2025

0000080255-25-000842

—

7.6 KB

Nov 12, 2025

0001193125-25-2780384

Nov 10, 2025

33.0 KB

S-3

Nov 6, 2025

0001104659-25-107397FORM S-3

—

1.6 MB

10-Q

Nov 6, 2025

0001689375-25-00005010-Q

Sep 30, 2025

6.2 MB

25 filings shown

Filed	Form	Description
6/3/25	DEFA14A	DEFA14A	→
4/25/25	DEFA14A	DEFA14A	→
4/25/25	DEF 14A	DEF 14A	→
4/29/24	DEFA14A	DEFA14A	→
4/29/24	DEF 14A	DEF 14A	→
4/19/24	PRE 14A	PRE 14A	→
↓

Entrada Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(425 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/6/26	4	4	→
3/3/26	4	4	→
3/3/26	4	4	→
3/3/26	4	4	→
3/3/26	4	4	→
11/24/25	4	4	→
↓

Filed	Form	Description
3/9/26	144	144	→
3/9/26	144	144	→
3/4/26	144	144	→
12/3/25	EFFECT	EFFECT	→
11/25/25	SCHEDULE 13G	SCHEDULE 13G	→
11/21/25	144	144	→
↓